Aspirin tolerance following omalizumab therapy in a patient with aspirin-exacerbated respiratory disease

Allergol Immunopathol (Madr). 2013 May-Jun;41(3):208-10. doi: 10.1016/j.aller.2012.02.005. Epub 2012 Jul 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Aspirin / adverse effects
  • Asthma, Aspirin-Induced / drug therapy*
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / immunology
  • Female
  • Humans
  • Immunoglobulin E / immunology*
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / blood
  • Middle Aged
  • Omalizumab

Substances

  • Anti-Allergic Agents
  • Anti-Asthmatic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal, Humanized
  • IL10 protein, human
  • Interleukin-10
  • Omalizumab
  • Immunoglobulin E
  • Aspirin